A cardiologist at the University of Chicago Medicine has performed the first cardioneural ablation in U.S. history, using it to “rewire” the heart of a patient suffering from vasovagal syncope.

Such attributes as patient outcomes, efficiency and available resources were used to develop the list, which includes a tie at No. 10. 

So what, exactly, occurs inside the human heart during a myocardial infarction?

Adding lung ultrasound to a STEMI patient’s Killip classification leads to a more thorough, effective assessment, according to new findings published in Circulation: Cardiovascular Imaging.

Researchers have found a link between myocardial injury and a higher risk of death among patients hospitalized in the United States for COVID-19.

Tafamidis received FDA approval in May 2019 for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM). It has a list price of $225,000 per year.

The VERTIS CV Study tracked the performance of ertugliflozin and a placebo in more than 8,000 adult T2D patients.

Why dexamethasone could be a legitimate game-changer in the fight against COVID-19—and an update on the FDA and hydroxychloroquine.

Outpatient prescriptions for azithromycin are associated with an increased risk of cardiovascular mortality, according to new research published in JAMA Network Open.